207 related articles for article (PubMed ID: 16188134)
21. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
22. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens.
Maguire B; Whitaker D; Carrello S; Spagnolo D
Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591
[TBL] [Abstract][Full Text] [Related]
24. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
25. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
Illingworth AL; Young JA; Johnson GD
Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
[TBL] [Abstract][Full Text] [Related]
26. The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells.
Lv M; Cha N; Zou YF; Leng JH; Hao YY; Wang S
Diagn Cytopathol; 2021 Jul; 49(7):811-816. PubMed ID: 33818924
[TBL] [Abstract][Full Text] [Related]
27. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases.
Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B
Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861
[TBL] [Abstract][Full Text] [Related]
28. [GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions].
Daste G; Gioanni J; Lauque D; Kremps M; Mazeau C; Paquis P; Schneider M
Arch Anat Cytol Pathol; 1997; 45(4):185-91. PubMed ID: 9406475
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion.
Ueda J; Iwata T; Ono M; Takahashi M
Diagn Cytopathol; 2006 Jan; 34(1):6-10. PubMed ID: 16355377
[TBL] [Abstract][Full Text] [Related]
31. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block.
Gong Y; Sun X; Michael CW; Attal S; Williamson BA; Bedrossian CW
Diagn Cytopathol; 2003 Jan; 28(1):1-5. PubMed ID: 12508174
[TBL] [Abstract][Full Text] [Related]
32. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S
Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294
[TBL] [Abstract][Full Text] [Related]
33. [The immunocytochemical study of pleural effusion and ascites using Ber-EP-4 antibodies].
Spehn J; Iwanetz S; Schmitz-Huebner U
Dtsch Med Wochenschr; 1995 Sep; 120(36):1197-200. PubMed ID: 7671771
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4.
De Angelis M; Buley ID; Heryet A; Gray W
Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160
[TBL] [Abstract][Full Text] [Related]
35. Morphologic and immunocytochemical performances of effusion cell blocks prepared using 3 different methods.
Jing X; Li QK; Bedrossian U; Michael CW
Am J Clin Pathol; 2013 Feb; 139(2):177-82. PubMed ID: 23355202
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
37. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
38. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
Pillai V; Cibas ES; Dorfman DM
Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
[TBL] [Abstract][Full Text] [Related]
39. Ber-EP4 staining in effusion cytology: A potential source of false positives.
Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
[TBL] [Abstract][Full Text] [Related]
40. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
